Send us Feedback

Chemgenex Pharmaceuticals (CXSP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
ChemGenex bid in hands of Teva
The Australian  May 3  Comment 
THE takeover of Melbourne-based ChemGenex has again been thrown onto the global biotech stage, with Teva trumping Valeant's bid for Cephalon.
Biotech caught in bidding circus
The Australian  May 3  Comment 
Cephalon (CEPH) Lodge Bidder's Statement for Acquisition of ChemGenex Pharma
StreetInsider.com  Apr 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cephalon+%28CEPH%29+Lodge+Bidder%27s+Statement+for+Acquisition+of+ChemGenex+Pharma/6425804.html for the full story.
ChemGenex suitor hit with $5.3bn bid
The Australian  Mar 30  Comment 
CHEMGENEX Pharmaceuticals has assured shareholders its friendly takeover by Cephalon is safe.
Valeant complicates ChemGenex bid
The Australian  Mar 30  Comment 
Cephalon continues buyout spree with $163M ChemGenex deal
FierceBiotech  Mar 29  Comment 
Just a week after striking a deal to buy out Gemin X for up to $525 million, Cephalon ($CEPH) is continuing its buyout spree with yet another acquisition of a small cancer drug developer with a late-stage product in hand. Cephalon will shell...
Cephalon to Bid for Australia's ChemGenex
TheStreet.com  Mar 29  Comment 
FRAZER, Pennsylvania (TheStreet) -- Cephalon intends to make a takeover bid for ChemGenex Pharmaceuticals, the Australian biopharmaceutical company. The total offer value for ChemGenex shares and listed ChemGenex options that Cephalon...
Cephalon Launches $231 Million Bid For ChemGenex Pharmaceuticals
Penny Stock DD  Mar 29  Comment 
Cephalon Inc. (CEPH: News ) announced Monday an A$225 million or $231 million bid for Australian biopharmaceutical company ChemGenex. The recommended takeover bid by Cephalon's wholly-owned subsidiary, Cephalon CXS Holdings Pty Ltd was ...
ChemGenex soars 53pc on Cephalon offer
The Australian  Mar 29  Comment 
SHARES in ChemGenex soared 50 per cent-plus after it agreed to a takeover offer by Cephalon that valued the target at $225 million.
ChemGenex soars on Cephalon takeover
The Australian  Mar 29  Comment 
Cephalon to make takeover bid valuing Australian biopharmaceutical company ChemGenex at $231M
Canadian Business  Mar 29  Comment 
Cephalon to buy ChemGenex Pharmaceuticals
MarketWatch  Mar 28  Comment 
Cephalon Inc. said Tuesday that it has offered 70 Australian cents (72 cents) a share to buy ChemGenex Pharmaceuticals Ltd. . The offer values ChemGenex at approximately A$225 million. Cephalon intends to fund the transaction from available cash...
Cephalon Signs Investment Agreement to Fund ChemGenex Clinical Development Operations
Benzinga  Oct 22  Comment 
Today, Cephalon, Inc. (Nasdaq: CEPH) announced the signing of a convertible note subscription agreement with ChemGenex Pharmaceuticals Limited. Under the terms of the agreement, Cephalon will provide up to A$15 million to ChemGenex in return...
ChemGenex shares surge after approval
Sydney Morning Herald  Jul 14  Comment 
ChemGenex Pharmaceuticals shares surged after it announced a breakthrough with the US Food and Drug Administration regarding the approval of a new cancer drug.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 



References

Retrieved from "http://www.wikinvest.com/stock/Chemgenex_Pharmaceuticals_(CXSP)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki